Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2168 POSTS 0 COMMENTS

https://psynews.com

PT498 – Traversing the Psychedelic Landscape: From Esalen and Millbrook to...

PT497 – Reflections from Shulgin Farm: Psychedelics, Legacy, and the Spirit...

Pα+ Psychedelic Bulletin #159: Patient Access to MDMA-Assisted Therapy; Notes from...

First Proof that Psilacetin is a Prodrug of Psilocin

Notes from the International Society for Research on Psychedelics’ 2024 Conference...

The Psychedelic News Feed: Feb 5, 2024 – Mar 3, 2024

PT496 – Maintenance Doses and Recurring Revenue: The Ethics of At-Home...

Fluence’s Elizabeth Nielson on Professional Education for the Psychedelics Field

How Long Does A Microdose Last?

Natural Medicine Advisory Bulletin 9

1...252627...217 Page 26 of 217

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin